Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders
Lana J Williams, Julie A Pasco, Felice N Jacka, Jason M Hodge, Mark A Kotowicz, Michael Berk
Journal of Affective Disorders | ELSEVIER SCIENCE BV | Published : 2013
Lana Williams has received Grant/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC.Julie Pasco has received speaker fees from Amgen, Eli Lilly and Sanofi-Aventis and funding from the Geelong Region Medical Research Foundation, Barwon-Health, Perpetual Trustees, the Dairy Research and Development Corporation, The University of Melbourne, the Ronald Geoffrey Arnott Foundation, ANZ Charitable Trust, the American Society for Bone and Mineral Research, Amgen (Europe) GmBH and the NHMRC.Felice Jacka has received Grant/Research support from the Brain and Behaviour Research Institute, NHMRC, Australian Rotary Health, Geelong Medical Research Foundation and The University of Melbourne, and has been a paid speaker for Sanofi-Synthelabo, Janssen Cilag, Servier, Pfizer, Network Nutrition, Health Ed and Eli Lilly.Michael Berk has received Grant/Research Support from the NIH, Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. He has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi-Synthelabo, Solvay and Wyeth.The study was funded by the National Health and Medical Research Council, Australia.